Healthcare Realty Trust (NYSE:HR) had its target price dropped by equities research analysts at Stifel Nicolaus from $34.00 to $30.00 in a research report issued on Thursday. The firm currently has a “buy” rating on the real estate investment trust’s stock. Stifel Nicolaus’ price target would indicate a potential upside of 8.30% from the stock’s previous close.

Several other research firms have also recently issued reports on HR. TheStreet cut shares of Healthcare Realty Trust from a “b” rating to a “c+” rating in a research note on Thursday, November 9th. Cantor Fitzgerald reiterated a “buy” rating and issued a $38.00 target price on shares of Healthcare Realty Trust in a research note on Wednesday. Mizuho reiterated a “hold” rating and issued a $34.00 target price on shares of Healthcare Realty Trust in a research note on Sunday, November 5th. BMO Capital Markets reiterated a “buy” rating and issued a $34.00 target price on shares of Healthcare Realty Trust in a research note on Thursday, November 2nd. Finally, Zacks Investment Research upgraded shares of Healthcare Realty Trust from a “sell” rating to a “hold” rating in a research note on Monday, November 6th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and four have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $32.50.

Healthcare Realty Trust (NYSE:HR) opened at $27.70 on Thursday. The company has a market cap of $3,523.15, a P/E ratio of 28.56, a P/E/G ratio of 4.25 and a beta of 0.20. Healthcare Realty Trust has a fifty-two week low of $27.48 and a fifty-two week high of $36.25. The company has a quick ratio of 2.82, a current ratio of 2.82 and a debt-to-equity ratio of 0.63.

Healthcare Realty Trust (NYSE:HR) last released its quarterly earnings data on Wednesday, February 14th. The real estate investment trust reported $0.38 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.39 by ($0.01). Healthcare Realty Trust had a return on equity of 6.62% and a net margin of 26.70%. The business had revenue of $107.70 million during the quarter, compared to the consensus estimate of $109.91 million. During the same period last year, the business posted $0.41 earnings per share. The firm’s quarterly revenue was up 2.3% on a year-over-year basis. analysts predict that Healthcare Realty Trust will post 1.55 earnings per share for the current year.

In other news, EVP John M. Bryant, Jr. sold 6,638 shares of the firm’s stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $32.38, for a total transaction of $214,938.44. Following the sale, the executive vice president now owns 176,812 shares in the company, valued at approximately $5,725,172.56. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Robert E. Hull sold 1,495 shares of the firm’s stock in a transaction on Monday, December 18th. The shares were sold at an average price of $33.87, for a total transaction of $50,635.65. Following the sale, the executive vice president now owns 94,796 shares in the company, valued at approximately $3,210,740.52. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 16,847 shares of company stock worth $551,491. Corporate insiders own 1.85% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. BlackRock Inc. raised its position in shares of Healthcare Realty Trust by 4.1% during the 4th quarter. BlackRock Inc. now owns 16,875,873 shares of the real estate investment trust’s stock valued at $542,051,000 after buying an additional 661,764 shares in the last quarter. Deutsche Bank AG raised its position in shares of Healthcare Realty Trust by 59.8% during the 4th quarter. Deutsche Bank AG now owns 5,088,632 shares of the real estate investment trust’s stock valued at $163,441,000 after buying an additional 1,905,183 shares in the last quarter. Macquarie Group Ltd. raised its position in shares of Healthcare Realty Trust by 4.5% during the 4th quarter. Macquarie Group Ltd. now owns 2,051,626 shares of the real estate investment trust’s stock valued at $65,868,000 after buying an additional 87,851 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Healthcare Realty Trust by 2.8% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,682,022 shares of the real estate investment trust’s stock valued at $54,397,000 after buying an additional 45,645 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. raised its position in shares of Healthcare Realty Trust by 7.2% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 1,677,757 shares of the real estate investment trust’s stock valued at $53,890,000 after buying an additional 112,412 shares in the last quarter. Hedge funds and other institutional investors own 93.24% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be read at https://theolympiareport.com/2018/02/15/healthcare-realty-trust-hr-price-target-lowered-to-30-00-at-stifel-nicolaus.html.

About Healthcare Realty Trust

Healthcare Realty Trust Incorporated is a self-managed and self-administered real estate investment trust. The Company owns, leases, manages, acquires, finances, develops and redevelops real estate properties associated primarily with the delivery of outpatient healthcare services across the United States.

Analyst Recommendations for Healthcare Realty Trust (NYSE:HR)

Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.